²³´´µ b+3¶ + · +3¸,+ 19 ,**+ ῌ The effect of parathyroid function on cardiovascular disease of maintainance dialysis patients KANEKO Tetsuya, KITAMURA Hiroshi, MIZUI Masayuki, MATSUI Isao, YAMAMOTO Satoshi, FUJITA Yoshimasa and FUJII Masamitsu Key words : &|1-'{jY - D x}?~z1 -'{jY . D CaP 12"!E#="j ! Y F3J J 34F/%@A! !"#$%&'()*"+#,-.!$ῌ/ 1,#="YG7U;:'T34'5 %&012'34'5 63 7 631,'7 78(19:;<='5 > 19:; Rostand SG ZHI+D ,-. ?@A BC PTHD E)* + +F3 GH! Geoffrey ZHI,D jkJH(KT4'5 GH IJK;LM&'5 ZoApqg?@A!LU;: ,-.,-.N JO/ '63<@&="34'5 P!0Q;:'R!SQ; 63M z1&E PTH B1 intact῍PTHD 12T3'34'5 ) !0Q(,-. 14U; V5W "7/% NU;:' X6YZ[?\%7!]^_`abcA D 8 1&19:;LMU 9 d:;ebfg?<=%7 BPEITD (:5 >hi BPTXD jkTlmnH PTH ?ToAp qg?nH;:'5 UYU YZr +4 ῌ 63oApqg?&=" PTH @A?19:; + D 1& oAsAt\TBZH;:j:5 *u ,-.1,:; PTH O 1-'vw + D PTH CDE)j Ca APQuE)1-FcpoAy , D xyAzjk!{(Z ATP !RSU;1 T Y *+ ,-.1,'¡¢j PTH z14&'E) ῌV £ Ca PzU¤Vh ῌz¥ £ ¦893§ ;893u ῌ £ ¦893N UYUcpoAy ATP !"(UW¨;1 ῌO £ O Ca N X ©ªY«¬ ῌ*Z £ y[\5W®0 A\yA]¯ z^°O Ca N z_±¬ _±¬ `a_±¬ ³´µ¶¶£ ¤+3· + ¸ 20 PTX _`3 Y* ^EF%a bACc3& */ PTX KL^EF&;%*JyDyE 56de !"#$% & *3456%sF G0 "& '() *+ ,- %& EBCT2 a #1( PTH !$. / !0%" yDyEhijk& & electronῌbeam computed tomography fg*J ,5 022 #1& -5 .2 % #1- Johann *^EF "#%34 &;%0l T5*emn 5 , 2 56789: 9JE|M 59jA PTH {E*em '56*$%&;%'<( sV 02 o Raggi * Ca =56&;%*'( >) ?P // mg,ῌdl, pq &; &;%*+ PTH ,-./ Ca % 56rs( it' uv ?P @ABCDE ./< jw F 12 Geof- F G056&;%*1H>) frey *59JE|M 34,340 mgῌdl 59j &;%*+IJKLM*"2N A ,4//4/ mgῌdl Ca?P // mg,ῌdl, wx yF iῌPTH +**,** 34O*56 P&;%Q *RID S56T Ca 5 T P 5UV pgῌml @ABCDEF& ,2 Goodman *z0l+3 1 <{' WF PmetastaticQ % 7X8Y5 ( N,-2 | 0l / 59 P } 659 Ca 59 P :;FWF ~ Ca?P 3 Ca T'^EF PdystrophicQ % , <=& &;%n 22 #1* 3>>)&;%* PmetastaticQ (M& 59 P 59 Ca PTH Ca? ?@ Geoffray *56Z P O<F =p:; &;%*[\AB]= CD (^EF&;%59+5,/ῌzA D ,2 =^EF_`%Ga*bc. }~# e#1&!32 '( H%< .Id #1&!b% .|= EBCT ¡+G =J?&;%WF "& (¢£¤jJE CT ^EFa /2 KL#1 !^EF&;%*M, -¥ ijk 59 Ca 59 P Ca?P PTH eN&! * ^EF9¦[~3= fOPF =Q + s<§~[¨fs 2 < PTH * Ca P RS-HT *© ª g9:& hU PTH * Hepatic tri- glyceride lipase ( i lipoprotein lipase V , 2 $3 X !59Bjkjlmno,- LDL W ' )*T5 5 p p HDL qM 'r l § >; «¬z®>; s!,3>EF_`%tN 4u tN / !0% & * ,X = PTH $. ¡$&;%#1 YZ>;EF`%eN Rostand *$&;% PTH * e *n Ca?P * e&V ,4 !"# + 2 ^EF3 ,v <'^EF3 +*2 ,^EF3 ¯5 %t' °p V '$3 - 2 t' &;%3(&w *i= Braun *,2s12='.3 ¡ x[,`3(,JyDyEnAzD{A /3±¢8<&;% //±EF |}A\]~^( ^EF&;%*1 &;%-#1 ^EF& H3'<*H=$ ;%@²EF&;%* e&V µ¶c · ῌd7QRS¸-)KL*%®¯ 21 0 minD^ DWD^ ©ª\V«©¬@8 CaP Al Z[M,6 6^_ ++ !"# )KL*%LJO%)®¯ $%&'()*+ fg hCWmn'^ °)KL ,-.'!&*+ *%L9FB±OJ . / 0 12)3*45 6,-7 !89&': ;)<=> ?@ABC@DE@"# 3F9G)$%3&'( H9)I#<= J=*)KL* %+,6-9MN' 9<=!& *+ .OP!/01QRS 2))KL*%T@UVBWX > Y/T@Z@[\3,4> ] 5 Ca^ ]5 P^ CaP T@UVBW9_`a )KL* PEIT^ PTX %9b6cd 7+eP 4fghCW*iA j@ D 8 PTH 9:;<9k%lJ mn%lopq9r=cd7s t uLvw PTH >?x. O;< @'O+oiAj@ D 8 yAzmn*OI#<=> {0&'iAj@ D |}8]~ 9BcOC"#*+ 4D WDE P ]T@UVBW Ca ]9Fd7+a Ca 94 P G OHn*I`a >>T@UVBW)!&J JhCWK> '<=> -4 )KL*%Lo]~M, <=>B\N) Kruz > LbOyP*y Ca BQ '|} Ca 82^ ]5 Ca R Se)d79+, )KL* %LyAzbOLo^ y Ca, P B%LL *^ WDE ^ iAj@ D 8^ T 6]5 Ca e^ UV WX2*&5 ¡eP ¢metastatic£ %lY]~o< => )KL*%LH^ ¤Wj¥Z [ ^ ^ ?\^ CAPD^ ] ¦ §7¨ Vita- ²`a<=> ³8^ )KL*%L -]~-´KFb + Rostand SG, Drueke TB : Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure : Kidney Int, /0 ; -2-, +333. , Geoffrey A, Block MD, et al : Reῌevaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients : Recommendations for a change in management, Am J Kidney Dis, -/ ; +,,0, ,***. - Simons C, Fortune F, Greenbaum RA et al : Cardiac hypertrophy, hypertrophic cardiomyopathy and hyperparathyroidismῌan association : Br Heart J, /. ; /-3, +32/. . Mall G, et al : Myocardial interstitial fibrosis in experiment uremiaῌimplication for cardiac complicance. Kidney Int, -- ; 2*., +322. / Wexler L, et al : Coronary artery calcification : Pathophysiology, epidemiology, imaging methods and clinical implications : A statement for health professionals from American Heart Association : Circulation, 3. ; ++1/, +330. 0 Johann et al : Electron beam computed tomography in the evaluation of cardiac calcifications in chronic dialysis patients : Am J Kidney Dis, ,1 ; -3., +330. 1 Raggi P : Detection and quantitification of cardiovascular calcifications with electron beam tomography to estimate risk in hemodialysis patients : Clin Nephrol, /. ; -,/, ,***. 2 Goodman WG et al : Coronaryῌartery calcification in young adults with endῌstage renal disease who are undergoing dialysis : N Engl J Med, -., ; +.12, ,***. 3 Karol E, Walton, MD et al : Active serum vitamin D levels are inversely corrected with coronary calcification. Circulation 30 ; +1//, +331. +* Rostand SG, et al : Myocardial calcification and cardiac dysfunction in chronic renal failure : Am J Med, 2/ ; 0/+, +322. ++ Ribeiros et al : Cardiac valve calcification in haemodialysis patients : role of calciumῌphosphate metabolism : Nephrol Dial Transplant +- ; ,*-1, +332. +, Kurz P et al : Evidence for abnormal calcium homeostasis in patients with adynamic bone disease : Kidney Int, /0 ; 2//, +33..
© Copyright 2025 ExpyDoc